Effect of Migraine Headache on Productivity of Patients According to Migraine Disability Assessment Score: A Cross-Sectional Study.

Functional disability Headache Loss of productivity Migraine

Journal

Pain and therapy
ISSN: 2193-8237
Titre abrégé: Pain Ther
Pays: New Zealand
ID NLM: 101634491

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 21 04 2019
pubmed: 11 7 2019
medline: 11 7 2019
entrez: 11 7 2019
Statut: ppublish

Résumé

Migraine, a primary headache disorder, is usually recurrent with moderate to severe intensity. Migraine is the third most common cause of disability under the age of 50. There are various scoring systems for assessing this disability, one of which is MIDAS; the Migraine Disability Assessment Score. The objective of our study was to determine the extent of disability among migraine patients, patterns of prophylaxis, and their healthcare-seeking behaviors. This survey was done in 50 migraine patients at Jinnah postgraduate medical Centre from April to May 2018. The questionnaire inquired about the demographic information, management of migraine, and effect of this condition on their sleep, and the last part had assessment to know about their functional disability. The majority of the patients were females with a mean age of 31 ± 10 years. Acetaminophen was the most common medication used during a migraine attack, followed by nonsteroidal anti-inflammatory drugs. Only 54% of subjects admitted using prophylaxis, out of which 94% had stopped taking it after some time, with the most common reason being their side effects. β-blockers were the most common prophylaxis used. Only 32% had a regular follow-up visit with their doctors. Patients were graded according to the MIDAS score as: little or no disability, 22%; mild disability, 14%; moderate disability, 24%; and severe disability, 40%. The majority of migraine patients were found to have severe disability, which affected their daily work and social activities. Despite an increase in disability rate due to migraine, people do not seek regular medical care for this type of headache in Pakistan.

Identifiants

pubmed: 31290014
doi: 10.1007/s40122-019-0130-4
pii: 10.1007/s40122-019-0130-4
pmc: PMC6857116
doi:

Types de publication

Journal Article

Langues

eng

Pagination

233-238

Références

Cephalalgia. 2018 Jan;38(1):1-211
pubmed: 29368949
J Headache Pain. 2017 Dec;18(1):35
pubmed: 28321593
J Pak Med Assoc. 2016 Feb;66(2):159-64
pubmed: 26819160
Indian J Psychiatry. 2018 Apr-Jun;60(2):224-228
pubmed: 30166680
Neurol Sci. 2014 May;35 Suppl 1:23-6
pubmed: 24867830
Acta Neurol Belg. 2015 Jun;115(2):117-22
pubmed: 24889393
J Neurol Sci. 2013 Mar 15;326(1-2):10-7
pubmed: 23394974
Headache. 2013 Apr;53(4):644-55
pubmed: 23458496
Eur J Neurol. 2008 Aug;15(8):817-21
pubmed: 18549394
Iran J Neurol. 2011;10(3-4):39-42
pubmed: 24250844
Neurol Sci. 2004 Oct;25 Suppl 3:S272-3
pubmed: 15549557
J Headache Pain. 2017 Dec;18(1):28
pubmed: 28229320
Handb Clin Neurol. 2015;131:447-63
pubmed: 26563803
Headache. 2012 Nov-Dec;52(10):1456-70
pubmed: 22830411
Biomed Res Int. 2014;2014:978064
pubmed: 24527462
PLoS One. 2009 Jun 08;4(6):e5827
pubmed: 19503794
Headache. 2001 Oct;41(9):854-61
pubmed: 11703471
Neurol Sci. 2015 May;36 Suppl 1:9-11
pubmed: 26017503
J Headache Pain. 2005 Dec;6(6):429-40
pubmed: 16388337
Neurology. 2001;56(6 Suppl 1):S20-8
pubmed: 11294956
Headache. 2008 Oct;48(9):1349-55
pubmed: 18194304
Eur J Neurol. 2018 Oct;25(10):1193-1194
pubmed: 29938876
Cephalalgia. 2014 May;34(6):426-33
pubmed: 24322480

Auteurs

Shafaq Jawed (S)

Jinnah Sindh Medical University, Karachi, Pakistan.

Waqar Ali (W)

Dow University of Health Sciences, Karachi, Pakistan.

Uzair Yaqoob (U)

Dow University of Health Sciences, Karachi, Pakistan. ozair_91393@hotmail.com.

Shahnaz Shah (S)

Jinnah Postgraduate Medical Centre, Karachi, Pakistan.

Syed Mohammad Mazhar Uddin (SMM)

Dow University of Health Sciences, Karachi, Pakistan.

Aatera Haq (A)

Dow University of Health Sciences, Karachi, Pakistan.

Classifications MeSH